Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London stocks slip on fears of second virus wave; BP slides

Mon, 15th Jun 2020 09:29

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* BP tumbles on writing off up to $17.5 bln in asset value

* Miners, energy stocks lead declines

* Bunzl jumps on upbeat revenue forecast

* FTSE 100 down 0.7%, FTSE 250 up 0.07%
(Adds comment, updates to close)

June 15 (Reuters) - London's FTSE 100 fell on Monday but
ended well off session lows, and mid-caps cut all their losses
towards the close after a surge in new cases of the novel
coronavirus in Beijing and underwhelming data from China knocked
markets at open.

Leading losses among European peers, the FTSE 100 closed
down 0.7% but recovered from a three-week low hit during the
session.

BP Plc weighed the most on the commodity-heavy index,
sliding 2.2% after saying it would write off up to $17.5 billion
in the value of its assets. A drop in base metal prices also
weighed.

Topping the FTSE 100, business supplies distributor Bunzl
jumped 9.8% after forecasting an increase in revenue
for the first half of the year, while AstraZeneca rose
1%.

The mid-cap FTSE 250 index ended flat as losses in
mining and some consumer stocks were offset by
gains in financials and defensive sectors such as real estate
and utilities.

Concerns of a slower economic recovery rose as Beijing
reinstated curbs after an unexpected spike in cases, and on
downbeat China factory data. In Britain, data showed footprint
in shopping centres fell nearly 82% from a year earlier.

The travel sector, one of the biggest
casualties of the pandemic-driven slump in demand, was off 1.3%.
Low-cost airline easyJet shed 4.6% even as it resumed
flying for the first time since March 30.

UK stock markets last week halted a robust two-month rally
as optimism around easing lockdowns was dulled by a grim
forecast by the U.S. Federal Reserve and a resurgence in
COVID-19 cases.

Investors now await the Bank of England meeting later this
week.

"We expect them to leave the policy rate unchanged at 0.1%
and to add 100 billion of quantitative easing purchases," said
Peder Beck-Friis, portfolio manager, global macro at PIMCO, who
sees negative rates as unlikely.
(Reporting by Sagarika Jaisinghani, Shashank Nayar and Susan
Mathew in Bengaluru; additional reporting by Aaron Saldanha;
editing by Uttaresh.V; editing by Jonathan Oatis)

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.